Autonomic dysfunction in patients with progressive supranuclear palsy

Movement Disorders

Volumn 23, Issue 14, 2008, Pages 2083-2089

  Schmidt, Claudia ^a   Herting, Birgit ^a   Prieur, Silke ^a   Junghanns, Susann ^a   Schweitzer, Katherine ^b   Reichmann, Heinz ^a   Berg, Daniela ^b   Ziemssen, Tjalf ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Autonomic dysfunction; Autonomic testing; Progressive supranuclear palsy

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CABERGOLINE; CATECHOL METHYLTRANSFERASE INHIBITOR; DIHYDROERGOCRYPTINE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR SYSTEM EXAMINATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS;

AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 57049106264     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22289     Document Type: Article

References (24)

1. Rampello L, Butta V, Raffaele R, et al. Progressive supranuclear palsy: a systematic review. Neurobiol Dis 2005;20:179-186.
2. Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathol 2007;17:74-82.
3. Schmidt C, Herting B, Prieur S, et al. Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes. Mov Disord 2007;22:2123-2126.
4. Kimber J, Mathias CJ, Lees AJ, et al. Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. Brain 2000;123 (Part 7):1422-1430.
5. Kikkawa Y, Asahina M, Suzuki A, Hattori T. Cutaneous sympathetic function and cardiovascular function in patients with progressive supranuclear palsy and Parkinson's disease. Parkinsonism Relat Disord 2003;10:101-106.
6. Deguchi K, Sasaki I, Tsukaguchi M, et al. Abnormalities of rate-corrected QT intervals in Parkinson's disease - a comparison with multiple system atrophy and progressive supranuclear palsy. J Neurol Sci 2002;199:31-37.
7. Brefel-Courbon C, Thalamas C, Rascol O, Montastruc JL, Senard JM. Lack of autonomic nervous dysfunction in progressive supranuclear palsy, a study of blood pressure variability. Clin Auton Res 2000;10:309-312.
8. Gutrecht JA. Autonomic cardiovascular re.exes in progressive supranuclear palsy. J Auton Nerv Syst 1992;39:29-35.
9. Sasaki I, Takeuchi H, Deguchi K, Yamada A, Nishioka M, Sakamoto H. Autonomic nervous function in progressive supranuclear palsy-comparison with Parkinson's disease and healthy controls. Clin Neurol (Rinsho Shinkeigaku) 1994;34:975-979.
10. Holmberg B, Kallio M, Johnels B, Elam M. Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of parkinsonian syndromes. Mov Disord 2001;16:217-225.
11. Sandroni P, Ahlskog JE, Fealey RD, Low PA. Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res 1991;1:147-155.
12. Wenning GK, Scherfler C, Granata R, et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 1999; 67:620-623.
13. van Dijk JG, Haan J, Koenderink M, Roos RA. Autonomic nervous function in progressive supranuclear palsy. Arch Neurol 1991;48:1083-1084.
14. Rub U, Del Tredici K, Schultz C, et al. Progressive supranuclear palsy: neuronal and glial cytoskeletal pathology in the higher order processing autonomic nuclei of the lower brainstem. Neuropathol Appl Neurobiol 2002;28:12-22.
15. Riley DE, Chelimsky TC. Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease. J Neurol Neurosurg Psychiatry 2003;74:56-60.
16. Schmidt C, Herting B, Prieur S, et al. Autonomic dysfunction in different subtypes of multiple system atrophy. Mov Disord (in press).
17. Hughes AJ, Daniel SE, Ben shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-870.
18. Litvan I, Agid Y, Caine D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson- Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
19. Ziemssen T, Reichmann H. Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2007;13:323-332.
20. Goldstein DS. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol 2003;2:669-676.
21. Bouhaddi M, Vuillier F, Fortrat JO, et al. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy. Auton Neurosci 2004;116:30-38.
22. Mesec A, Sega S, Kiauta T. The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses. Clin Auton Res 1993;3:339-344.
23. Kaufmann H. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 1996;6:125-126.
24. Sakakibara R, Hattori T, Tojo M, Yamanishi T, Yasuda K, Hirayama K. Micturitional disturbance in progressive supranuclear palsy. J Auton Nerv Syst 1993;45:101-106.